Table 2.
P63 expression of in current series and in other published series
|
Diagnosis |
Our series |
Dickson’s series [[4]] |
De la Rosa’s series [[3]] |
Lee’s series [[6]] |
||||
|---|---|---|---|---|---|---|---|---|
| N° of cases | P63+ cases (%) | N° of cases | P63+ cases (%) | N° of cases | P63+ cases (%) | N° of cases | P63+ cases (%) | |
| GCTOB |
5 |
100% |
17 |
100% |
23 |
86.9% |
6 |
81% |
| Osteosarcoma |
12 |
8.3% |
0 |
- |
4 |
50% |
13 |
15.3% |
| Osteoblastoma |
8 |
37.5% |
0 |
- |
0 |
- |
0 |
- |
| ABC |
5 |
40% |
7 |
28.6% |
8 |
62.5% |
25 |
20% |
| CGCG |
4 |
0% |
12 |
0% |
4 |
100% |
12 |
0% |
| NOF |
4 |
25% |
0 |
- |
6 |
16.6% |
0 |
- |
| OO |
4 |
50% |
0 |
- |
0 |
- |
0 |
- |
| CMF |
3 |
33.4% |
0 |
- |
0 |
- |
12 |
0% |
| Chondroblastoma |
1 |
100% |
10 |
30% |
12 |
83.3% |
15 |
40% |
| FD |
1 |
0% |
0 |
- |
2 |
0% |
4 |
0% |
| LCH |
1 |
0% |
0 |
- |
0 |
- |
0 |
- |
| chondrosarcoma |
0 |
- |
0 |
- |
0 |
- |
0 |
- |
| Brown tumor | 0 | - | 0 | - | 0 | - | 4 | 0% |